[Clinical study on the use of a prostaglandin E1 analog for therapeutical termination of pregnancy in the second trimester].
Martinelli
P
P
Locci
M
M
Votino
F
F
Arpaia
F
F
Di Meglio
G
G
Guerritore
T
T
Nicotra
A
A
Latorre
P C
PC
Giannitelli
A
A
Montemagno
U
U
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D000028:Abortion, Induced; D000032:Abortion, Therapeutic / Q000379:methods*; D000282:Administration, Intravaginal; D000293:Adolescent; D000328:Adult; D000527:Alprostadil / Q000031:analogs & derivatives*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D010570:Pessaries; D011247:Pregnancy; D011262:Pregnancy Trimester, Second
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; C021182:gemeprost; D000527:Alprostadil
Studio clinico sull'impiego di un analogo della prostaglandina E1 per l'interruzione terapeutica della gravidanza al ii trimestre.